XML 52 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Net Loss Per Share - Shares Excluded From Computation Of Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Apr. 30, 2019
Apr. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total common stock equivalents (in shares) 8,344 13,363      
0.25% Convertible Senior Notes Due 2023 | Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Face value $ 345,000,000   $ 345,000,000   $ 345,000,000
Conversion price         $ 26.95
0.25% Convertible Senior Notes Due 2023 | Senior Notes | Capped Call          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion price         $ 40.68
0.125% Convertible Senior Notes Due 2025 | Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Face value $ 800,000,000 $ 700,000,000 $ 800,000,000 $ 100,000,000  
Conversion price       $ 51.56  
0.125% Convertible Senior Notes Due 2025 | Senior Notes | Capped Call          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion price       $ 79.32  
Options to purchase common stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total common stock equivalents (in shares) 1,050 3,258      
RSUs and PSUs          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total common stock equivalents (in shares) 3,316 6,732      
Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total common stock equivalents (in shares) 3,968 3,332      
Employee stock purchase plan          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total common stock equivalents (in shares) 10 41